Emma Persson

Company: argenx BV
Job title: Scientist, Clinical
Seminars:
Safety, Efficacy, Pharmacokinetics & Pharmacodynamics of ARGX-117, a Therapeutic Antibody Targeting Complement Factor 2 12:20 pm
Evaluating how the ARGX-117 antibody has been engineered to have a long half life Demonstrating that administration of ARGX-117 in healthy volunteers is safe and well-tolerated ARGX-117 is being studied in adults with multifocal motor neuropathy in a Phase 2 clinical studyRead more
day: Track B - Day 1 AM